檢索結果 - Colin Hessel

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Safety, Efficacy, and Effectiveness of Live, Attenuated, Cold‐Adapted Influenza Vaccine in an Indicated Population Aged 5–49 Years

    Safety, Efficacy, and Effectiveness of Live, Attenuated, Cold‐Adapted Influenza Vaccine in an Indicated Population Aged 5–49 Years 由 Robert B. Belshe, Kristin L. Nichol, Steven B. Black, Henry R. Shinefield, Julie Cordova, Robert Walker, Colin Hessel, Iksung Cho, Paul M. Mendelman

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial

    Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-La... 由 Pedro A. Piedra, Manjusha Gaglani, Mark W. Riggs, Gayla B. Herschler, Charles Fewlass, Matt Watts, Claudia A. Kozinetz, Colin Hessel, W. Paul Glezen

    出版 2005
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials

    Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials 由 Benjamin M. Ellingson, Robert J. Harris, Davis C. Woodworth, Kevin Leu, Okkar Zaw, Warren Mason, Solmaz Sahebjam, Lauren E. Abrey, Dana T. Aftab, Gisela Schwab, Colin Hessel, Albert Lai, Phioanh L. Nghiemphu, Whitney B. Pope, Patrick Y. Wen, Timothy F. Cloughesy

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update

    Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free surv... 由 Toni K. Choueiri, Colin Hessel, Susan Halabi, Ben L. Sanford, M. Dror Michaelson, Olwen Hahn, Meghara Walsh, Thomas Olencki, Joel Picus, Eric J. Small, Shaker R. Dakhil, Darren R. Feldman, Milan Mangeshkar, Christian Scheffold, Daniel J. George, Michael J. Morris

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Cabozantinib in Progressive Medullary Thyroid Cancer

    Cabozantinib in Progressive Medullary Thyroid Cancer 由 Rossella Elisei, Martin Schlumberger, Stefan Müller, Patrick Schöffski, Marcia S. Brose, Manisha H. Shah, Lisa Licitra, Barbara Jarząb, В. С. Медведев, Michael C. Kreißl, Bruno Niederle, Ezra E.W. Cohen, Lori J. Wirth, Haythem Ali, Colin Hessel, Yifah Yaron, Douglas W. Ball, Barry D. Nelkin, Steven I. Sherman

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials

    Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials 由 Benjamin M. Ellingson, Elizabeth R. Gerstner, Marion Smits, Raymond Y. Huang, Rivka R. Colen, Lauren E. Abrey, Dana T. Aftab, Gisela Schwab, Colin Hessel, Robert J. Harris, Ararat Chakhoyan, Renske Gahrmann, Whitney B. Pope, Kevin Leu, Catalina Raymond, Davis C. Woodworth, John de Groot, Patrick Y. Wen, Tracy T. Batchelor, Martin J. van den Bent, Timothy F. Cloughesy

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

    Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma 由 Toni K. Choueiri, Bernard Escudier, Thomas Powles, Paul N. Mainwaring, Brian I. Rini, Frede Donskov, Hans J. Hammers, Thomas E. Hutson, Jae‐Lyun Lee, Katriina Peltola, Bruce J. Roth, Georg A. Bjarnason, Lajos Géczi, Bhumsuk Keam, Pablo Maroto, Daniel Y.C. Heng, Manuela Schmidinger, Philip W. Kantoff, Anne E. Borgman-Hagey, Colin Hessel, Christian Scheffold, Gisela Schwab, Nizar M. Tannir, Robert J. Motzer

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

    Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1 由 Matthew R. Smith, Johann S. de Bono, Cora N. Sternberg, Sylvestre Le Moulec, Stéphane Oudard, Ugo De Giorgi, Michael Krainer, Andries M. Bergman, Wolfgang Hoelzer, Ronald de Wit, Martin Bögemann, Fred Saad, Giorgio Cruciani, Antoine Thiery-Vuillemin, Susan Feyerabend, Kurt Miller, Nadine Houédé, Syed A. Hussain, Elaine T. Lam, Jonathan Polikoff, Arnulf Stenzl, Paul N. Mainwaring, David A. Ramies, Colin Hessel, Aaron Weitzman, Karim Fizazi

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

    Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma 由 Ghassan K. Abou‐Alfa, Tim Meyer, Ann‐Lii Cheng, Anthony B. El-Khoueiry, Lorenza Rimassa, Baek‐Yeol Ryoo, İrfan Çiçin, Philippe Merle, Yen-Hsun Chen, Joong‐Won Park, Jean-Frederic Blanc, Luigi Bolondi, Heinz‐Josef Klümpen, Stephen L. Chan, Vittorina Zagonel, Tiziana Pressiani, Min-Hee Ryu, Alan P. Venook, Colin Hessel, Anne E. Borgman-Hagey, Gisela Schwab, Robin Kate Kelley

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: